_256_384.jpg)
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
In financial year 2024-25, PMBJP has made sales of Rs. 1,760 crore (at MRP) till Feb 2025
The GMP inspection assessed mammalian and microbial drug substance manufacturing facility sections
Aims to achieve CDMO sales of US$ 400 million by 2028
Pegfilgrastim is a Pegylated form of the recombinant human granulocyte colony-stimulating factor (G-CSF) analogue Filgrastim
mRESVIA is Moderna's second approved product and the only RSV vaccine available in single-dose pre-filled syringes
This agreement paves the way for the introduction of YESAFILI into the Canadian market
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Receives registration of Valganciclovir powder for oral solution in Germany
Subscribe To Our Newsletter & Stay Updated
